Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants

Placenta

Volumn 32, Issue SUPPL. 1, 2011, Pages

  Grimpel, Y I ^a   Kivity, V ^a   Cohen, A ^a   Meiri, H ^a   Sammar, M ^a,b   Gonen, R ^c,d   Huppertz, B ^e  

^a Diagnostic Technologies Ltd   (Israel)

^b ORT BRAUDE COLLEGE   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aspirin; Calcium; Low molecular weight heparin; Magnesium placenta; PP13; Preeclampsia

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; PLACENTA PROTEIN; PLACENTA PROTEIN 13; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG EFFECT; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; CALCIUM; CELLS, CULTURED; FEMALE; GALECTINS; GESTATIONAL AGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MAGNESIUM; ORGAN CULTURE TECHNIQUES; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; YOUNG ADULT;

EID: 79151478935     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.11.019     Document Type: Article

References (45)

1. K.Y. Lain, and J.M. Roberts Contemporary concepts of the pathogenesis and management of preeclampsia JAMA 287 2002 3183 3186
2. B. Huppertz Placental origins of preeclampsia: challenging the current hypothesis Hypertension 51 2008 970 975
3. B.M. Sibai, and F.G. Cunningham Prevention of preeclampsia and eclampsia M.D. Lindheimer, J.M. Roberts, F.G. Cunningham, Chelsey's hypertensive disorders in pregnancy 2009 Elsevier Amsterdam 213 225
4. C. Lees First trimester screening for pre-eclampsia and fetal growth restriction: a test seeking both treatment and optimal time Ultrasound Obstet Gynecol 35 2010 647 649
5. E. Rey, P. Garneau, M. David, R. Gauthier, L. Leduc, and N. Michon Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial J Thromb Haemost 7 2009 58 64
6. A. Aris, S. Leblanc, A. Ouellet, and J.M. Moutquin Detrimental effects of high levels of antioxidant vitamins C and E on placental function: considerations for the vitamins in preeclampsia (VIP) trial J Obstet Gynaecol Res 34 2008 504 511
7. L. Poston, A.L. Briley, P.T. Seed, F.J. Kelly, and A.H. Shennan Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial Lancet 367 2006 1145 1154
8. L.M. Askie, L. Duley, D.J. Henderson-Smart, L.A. Stewart (on behalf of the PARIS Collaborative Group) Antiplatelets agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet 369 2007 1791 1798
9. L. Duley, D.J. Henderson-Smart, S. Meher, and J.F. King Antiplatelets agents for preventing pre-eclampsia and its complications Cochrane Database Syst Rev 2007 CD004659
10. K. Harrington, W. Kurdi, J. Aquilina, P. England, and S. Campbell A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks Ultrasound Obstet Gynecol 15 2000 13 18
11. A. Coomarasamy, S. Papaioannou, H. Gee, and K.S. Khan Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis Obstet Gynecol 98 2001 861 866
12. G.J. Hofmeyr, A.N. Atallah, and L. Duley Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems Cochrane Database Syst Rev 2006 CD001059
13. R.M. Nilsen, S.E. Vollset, S.A. Rasmussen, Ueland Per-M, and A.K. Daltveit Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study Am J Epidemiol 167 2008 867 874
14. S.W. Wen, X.K. Chen, M. Rodger, R.R. White, Q. Yang, and G.N. Smith Folic acid supplementation in early second trimester and the risk of preeclampsia Am J Obstet Gynecol 198 2008 45.e1 45.e7
15. E.W. Triche, L.M. Grosso, K. Belanger, A.S. Darefsky, N.L. Benowitz, and M.B. Bracken Chocolate consumption in pregnancy and reduced likelihood of preeclampsia Epidemiology 19 2008 459 464
16. J.M. Roberts, L. Myatt, C.Y. Spong, E.A. Thom, J.C. Hauth, and K.J. Leveno for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension N Engl J Med 362 2010 1282 1291
17. H. Xu, R. Perez-Cuevas, X. Xiong, H. Reyes, C. Roy, P. Julien the INTAPP study group An international trial of antioxidants in the prevention of preeclampsia (INTAPP) Am J Obstet Gynecol 202 2010 239.e1 239.e10
18. D. Altman, G. Carroli, L. Duley, B. Farrell, J. Moodley, J. Neilson Magpie Trial Collaboration Group Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial Lancet 359 2002 1877 1890
19. N.G. Than, B. Sumegi, G.N. Than, Z. Berente, and H. Bohn Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-leyden crystal protein Placenta 20 1999 703 710
20. O. Burger, E. Pick, J. Zwickel, M. Klayman, H. Meiri, and R. Slotky Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies Placenta 25 2004 608 622
21. N.G. Than, E. Pick, S. Bellyei, A. Szigeti, O. Burger, and Z. Berente Functional analyses of placental protein 13/galectin-13 Eur J Biochem 271 2004 1065 1078
22. N.G. Than, R. Romero, M. Goodman, A. Weckle, J. Xing, and Z. Dong A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death Proc Natl Acad Sci U S A 106 2009 9731e6
23. B. Huppertz, M. Sammar, I. Chefetz, P. Neumaier-Wagner, C. Bartz, and H. Meiri Longitudinal determination of serum placental protein 13 during development of preeclampsia Fetal Diagn Ther 24 2008 230 236
24. R. Gonen, R. Shahar, Y. Grimpel, I. Chefetz, M. Sammar, and H. Meiri Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study Br J Obstet Gynaecol 115 2008 1465 1472
25. N.G. Than, R.O. Abdul, R. Magenheim, B. Nagy, T. Fule, and B. Hargitai Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome Virchows Arch 453 2008 387 400
26. K.H. Nicolaides, R. Bindra, O.M. Turan, I. Chefetz, M. Sammar, and H. Meiri A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound Ultrasound Obstet Gynecol 27 2006 13 17
27. K. Spencer, N.J. Cowans, I. Chefetz, J. Tal, and H. Meiri First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia Ultrasound Obstet Gynecol 29 2007 128 134
28. I. Chafetz, I. Kuhnreich, M. Sammar, Y. Tal, Y. Gibor, and H. Meiri First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction Am J Obstet Gynecol 197 2007 35 37
29. R. Romero, J.P. Kusanovic, N.G. Than, O. Erez, F. Gotsch, and J. Espinoza First-trimester maternal serum PP13 in the risk assessment for preeclampsia Am J Obstet Gynecol 199 2008 e1 11
30. A. Khalil, N.J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk Prenat Diagn 209 2009 781 789
31. K. Spencer, N.J. Cowans, I. Chefetz, J. Tal, I. Kuhnreich, and H. Meiri Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia Prenat Diagn 27 2007 258 263
32. K. Spencer, N.J. Cowans, and K.H. Nicolaides Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia Prenat Diagn 28 2008 7 10
33. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
34. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
35. R. Akolekar, E. Zaragoza, L.C. Poon, S. Pepes, and K.H. Nicolaides Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia Ultrasound Obstet Gynecol 32 2008 732 739
36. M.A. Brown, M.D. Lindheimer, M. de Swiet, A. Van Assche, and J.M. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
37. R. Romero Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment Ultrasound Obstet Gynecol 30 2007 675 686
38. A.J. Racher, D. Looby, and J.B. Greffiths Use of lactate dehydrogenase release to assess changes in the culture viability Cytotechnology 3 1990 301 307
39. L. Duley, A. Gulmezoglu, and D. Henderson-Smart Magnesium sulphate and other anticonvulsants for women with pre-eclampsia Cochrane Database Syst Rev 2003 CD000025
40. A.R. Rumbold, C.A. Crowther, R.R. Haslam, G.A. Dekker, J.S. Robinson ACTS Study Group Vitamins C and E and the risks of pre-eclampsia and perinatal complications N Engl J Med 354 2006 1796 1806
41. Y. Wang, and S.W. Walsh Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas Free Radic Biol Med 18 1995 585 591
42. E. Bujold, S. Roberge, Y. Lacass, M. Bureau, F. Audiber, and S. Marcoux Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. A meta-analysis Obstet Gynecol 116 2010 402 414
43. K. Orendi, M. Gauster, G. Moser, H. Meiri, and B. Huppertz Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells Placenta 31 2010 431 438
44. J.M. Dodd, A. McLeod, R.C. Windrim, and J. Kingdom Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction Cochrane Database Syst Rev 6 2010 Jun 16 CD006780
45. E.W. Seely Calciotropic hormones in preeclampsia: a renewal of interest J Clin Endocrinol Metab 92 2007 3402 3403